Get Full access to Top 1000 data, subscribe from only €29

Register Now »
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data


By Turnover

(€241.5 million)

By Employees

267th in Top Companies By Turnover
  • 158
  • €241.5 million


  • Michael O’Donnell CEO/Managing Director

Latest News


Thanks, You are now signed up to the Top 1000 newsletter!